SLIT2 and central nervous system cancer: Accordingly, Robo4 inhibits glioma-induced EC proliferation, migration and tube formation by binding to its ligand Slit2, and thus, the first Robo4 targeting strategy is the injection of high doses of the recombinant Slit2 protein.